DERM Journey Medical Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: DERM

Price (delayed)

$6.5

Market cap

$183.46M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.22

Enterprise value

$183.36M

?
Relative Growth: Rel. Growth: 64
Relative Strength: Rel. Strength: 33
Relative Valuation: Rel. Valuation: 18
Relative Profitability: Rel. Profitability: 39
Highlights
The equity has surged by 67% year-on-year and by 4.2% since the previous quarter
DERM's EPS is up by 42% year-on-year and by 41% since the previous quarter
The company's quick ratio has surged by 52% YoY but it fell by 2.2% QoQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://journeymedicalcorp.com
Peers: BHC PRGO TEVA AMRX

Key stats

What are the main financial stats of DERM

DERM stock price

How has the Journey Medical stock price performed over time
Intraday
-10.34%
1 week
-10.84%
1 month
-16.13%
1 year
-13.45%
YTD
-15.69%
QTD
-8.19%

Financial performance

How have Journey Medical's revenue and profit performed over time
Revenue
$68.18M
Gross profit
$44.63M
Operating income
-$3.01M
Net income
-$6.1M
Gross margin
65.5%
Net margin
-9%
DERM's operating margin has soared by 64% YoY and by 55% QoQ
Journey Medical's operating income has surged by 56% YoY and by 53% QoQ
The net margin is up by 42% YoY and by 39% QoQ
Journey Medical's net income has increased by 36% QoQ and by 30% YoY

Price vs fundamentals

How does DERM's price correlate with its fundamentals

Growth

What is Journey Medical's growth rate over time

Valuation

What is Journey Medical stock price valuation
P/E
N/A
P/B
5.57
P/S
2.62
EV/EBIT
N/A
EV/EBITDA
96.81
EV/Sales
2.69
DERM's EPS is up by 42% year-on-year and by 41% since the previous quarter
DERM's price to book (P/B) is 98% lower than its 5-year quarterly average of 308.1 but 5% higher than its last 4 quarters average of 5.9
The equity has surged by 67% year-on-year and by 4.2% since the previous quarter
DERM's price to sales (P/S) is 95% higher than its 5-year quarterly average of 1.5 and 8% higher than its last 4 quarters average of 2.7
The revenue is up by 21% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is Journey Medical business performance
The ROIC has soared by 70% YoY and by 63% QoQ
DERM's return on sales has surged by 61% year-on-year and by 60% since the previous quarter
DERM's ROE has soared by 59% YoY and by 43% QoQ
Journey Medical's return on assets has increased by 42% YoY and by 39% QoQ

Dividends

What is DERM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DERM.

Financial health

How did Journey Medical financials performed over time
The company's total assets is 48% higher than its total liabilities
The company's quick ratio has surged by 52% YoY but it fell by 2.2% QoQ
Journey Medical's current ratio has increased by 25% YoY but it has decreased by 8% from the previous quarter
The debt is 20% lower than the equity
The equity has surged by 67% year-on-year and by 4.2% since the previous quarter
DERM's debt to equity is down by 39% year-on-year and by 3.6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.